2013 Q2 Form 10-Q Financial Statement

#000114420413045995 Filed on August 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $67.00K $56.00K
YoY Change 19.64% -74.55%
Cost Of Revenue $20.00K $63.00K
YoY Change -68.25% -37.0%
Gross Profit $47.00K -$7.000K
YoY Change -771.43% -105.83%
Gross Profit Margin 70.15% -12.5%
Selling, General & Admin $3.078M $1.091M
YoY Change 182.13% -50.63%
% of Gross Profit 6548.94%
Research & Development $0.00 $32.00K
YoY Change -100.0% -90.0%
% of Gross Profit 0.0%
Depreciation & Amortization $90.00K $30.00K
YoY Change 200.0% 50.0%
% of Gross Profit 191.49%
Operating Expenses $3.144M $1.123M
YoY Change 179.96% -55.61%
Operating Profit -$3.097M -$1.130M
YoY Change 174.07% -53.11%
Interest Expense -$4.320M -$710.0K
YoY Change 508.45% -7200.0%
% of Operating Profit
Other Income/Expense, Net -$3.573M -$709.0K
YoY Change 403.95%
Pretax Income -$6.670M -$1.839M
YoY Change 262.7% -23.69%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.579M -$1.636M
YoY Change 302.14% 12.83%
Net Earnings / Revenue -9819.4% -2921.43%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.379M -$777.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.300M $5.700M
YoY Change 10.53% 0.0%
Cash & Equivalents $6.348M $5.646M
Short-Term Investments
Other Short-Term Assets $200.0K $100.0K
YoY Change 100.0% -90.91%
Inventory $100.0K
Prepaid Expenses
Receivables $17.00K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.613M $5.800M
YoY Change 14.02% -17.14%
LONG-TERM ASSETS
Property, Plant & Equipment $53.00K $0.00
YoY Change -100.0%
Goodwill $4.972M
YoY Change
Intangibles $2.303M
YoY Change
Long-Term Investments $100.0K
YoY Change -50.0%
Other Assets $2.000K $600.0K
YoY Change -99.67%
Total Long-Term Assets $8.119M $2.500M
YoY Change 224.76% 525.0%
TOTAL ASSETS
Total Short-Term Assets $6.613M $5.800M
Total Long-Term Assets $8.119M $2.500M
Total Assets $14.73M $8.300M
YoY Change 77.49% 12.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $347.0K $300.0K
YoY Change 15.67% -57.14%
Accrued Expenses $99.00K $1.000M
YoY Change -90.1% 42.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $946.0K $1.300M
YoY Change -27.23% -13.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.500M
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $1.500M
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $4.000M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $946.0K $1.300M
Total Long-Term Liabilities $0.00 $4.000M
Total Liabilities $946.0K $9.800M
YoY Change -90.35% 24.05%
SHAREHOLDERS EQUITY
Retained Earnings -$289.1M
YoY Change
Common Stock $300.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.17M -$1.400M
YoY Change
Total Liabilities & Shareholders Equity $14.73M $8.300M
YoY Change 77.49% 12.16%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$6.579M -$1.636M
YoY Change 302.14% 12.83%
Depreciation, Depletion And Amortization $90.00K $30.00K
YoY Change 200.0% 50.0%
Cash From Operating Activities -$1.040M -$620.0K
YoY Change 67.74% -72.57%
INVESTING ACTIVITIES
Capital Expenditures -$210.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.880M -$200.0K
YoY Change -1040.0% -281.82%
Cash From Investing Activities $1.670M -$200.0K
YoY Change -935.0% -281.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.050M 3.130M
YoY Change -2.56%
NET CHANGE
Cash From Operating Activities -1.040M -620.0K
Cash From Investing Activities 1.670M -200.0K
Cash From Financing Activities 3.050M 3.130M
Net Change In Cash 3.680M 2.310M
YoY Change 59.31% -207.44%
FREE CASH FLOW
Cash From Operating Activities -$1.040M -$620.0K
Capital Expenditures -$210.0K $0.00
Free Cash Flow -$830.0K -$620.0K
YoY Change 33.87% -72.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
789000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2039000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6303846 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6303846 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3251187 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3251187 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6348000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3443000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.38
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4766904 shares
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
248000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
340000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
6613000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
3792000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2303000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1795000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2013Q2 us-gaap Assets
Assets
14732000 USD
CY2012Q4 us-gaap Assets
Assets
7651000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
347000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
242000 USD
CY2012Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
13000 USD
CY2012Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
43000 USD
CY2013Q2 us-gaap Other Cost Of Services
OtherCostOfServices
0 USD
CY2013Q2 mgt Cost Of Services Gaming
CostOfServicesGaming
20000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
20000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
47000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3144000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
1123000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1130000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
272000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
946000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
581000 USD
CY2013Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 USD
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7166000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
946000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
7747000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
300592000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
282998000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-289149000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-283631000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
11168000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-911000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
2503000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
768000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13671000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-143000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14732000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7651000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
4972000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
0 USD
CY2013Q2 mgt Loans Payable Related Parties Current
LoansPayableRelatedPartiesCurrent
100000 USD
CY2012Q4 mgt Loans Payable Related Parties Current
LoansPayableRelatedPartiesCurrent
0 USD
CY2013Q2 us-gaap Technology Services Revenue
TechnologyServicesRevenue
27000 USD
CY2013Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
22000 USD
CY2013Q2 us-gaap Technology Services Costs
TechnologyServicesCosts
0 USD
CY2012Q2 us-gaap Technology Services Costs
TechnologyServicesCosts
0 USD
CY2013Q2 us-gaap Revenues
Revenues
67000 USD
CY2012Q2 us-gaap Revenues
Revenues
56000 USD
CY2013Q2 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
18000 USD
CY2012Q2 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
0 USD
CY2012Q2 us-gaap Other Cost Of Services
OtherCostOfServices
63000 USD
CY2012Q2 mgt Cost Of Services Gaming
CostOfServicesGaming
0 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
63000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
-7000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1091000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2012Q2 mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
-23000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3144000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3097000 USD
CY2013Q2 mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
3000 USD
CY2013Q2 mgt Gain On Sale Of Medical Patents
GainOnSaleOfMedicalPatents
750000 USD
CY2012Q2 mgt Gain On Sale Of Medical Patents
GainOnSaleOfMedicalPatents
0 USD
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2012Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
76000 USD
CY2013Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-4326000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-610000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3573000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-709000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6670000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1839000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-6670000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-1839000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-91000 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-203000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-6579000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636000 USD
CY2013Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
7000 USD
CY2012Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6586000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1636000 USD
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2105187 shares
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
0 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-4000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-204000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6670000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1639000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6670000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1843000 USD
us-gaap Technology Services Revenue
TechnologyServicesRevenue
38000 USD
us-gaap Technology Services Revenue
TechnologyServicesRevenue
206000 USD
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
97000 USD
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
63000 USD
mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
18000 USD
mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
0 USD
us-gaap Revenues
Revenues
153000 USD
us-gaap Revenues
Revenues
269000 USD
us-gaap Technology Services Costs
TechnologyServicesCosts
0 USD
us-gaap Technology Services Costs
TechnologyServicesCosts
36000 USD
us-gaap Other Cost Of Services
OtherCostOfServices
63000 USD
us-gaap Other Cost Of Services
OtherCostOfServices
63000 USD
mgt Cost Of Services Gaming
CostOfServicesGaming
20000 USD
mgt Cost Of Services Gaming
CostOfServicesGaming
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
83000 USD
us-gaap Cost Of Revenue
CostOfRevenue
99000 USD
us-gaap Gross Profit
GrossProfit
70000 USD
us-gaap Gross Profit
GrossProfit
170000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4305000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1904000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2204000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-610000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1427000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-711000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5662000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73000 USD
us-gaap Operating Expenses
OperatingExpenses
4305000 USD
us-gaap Operating Expenses
OperatingExpenses
1977000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4235000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1807000 USD
mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
27000 USD
mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
-25000 USD
mgt Gain On Sale Of Medical Patents
GainOnSaleOfMedicalPatents
750000 USD
mgt Gain On Sale Of Medical Patents
GainOnSaleOfMedicalPatents
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
76000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2518000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Profit Loss
ProfitLoss
-5665000 USD
us-gaap Profit Loss
ProfitLoss
-2518000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-147000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-412000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5518000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2106000 USD
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
68000 USD
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5586000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2106000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.00
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5472423 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2106763 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
68000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5665000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2450000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-380000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5665000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2070000 USD
mgt Quarterly Dividend Preferred Stock Value
QuarterlyDividendPreferredStockValue
-68000 USD
mgt Conversion Of Preferred Stock To Common Stock Value
ConversionOfPreferredStockToCommonStockValue
3000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
705000 USD
mgt Conversion Of Warrants To Common Stock Value
ConversionOfWarrantsToCommonStockValue
290000 USD
mgt Conversion Of Series Preferred Stock To Warrants Value
ConversionOfSeriesPreferredStockToWarrantsValue
2757000 USD
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
202000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4900000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
503000 USD
mgt Adjustments To Additional Paid In Capital Reclassification Of Preferred Warrants Into Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfPreferredWarrantsIntoEquity
8206000 USD
mgt Adjustments To Additional Paid In Capital Reclassification Of Warrants Into Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIntoEquity
1164000 USD
mgt Adjustments To Additional Paid In Capital Sharebased Compensation Modification Of Warrants
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationModificationOfWarrants
817000 USD
us-gaap Depreciation
Depreciation
11000 USD
us-gaap Depreciation
Depreciation
15000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1208000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
229000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000 USD
mgt Amortization Of Convertible Note Discount
AmortizationOfConvertibleNoteDiscount
0 USD
mgt Amortization Of Convertible Note Discount
AmortizationOfConvertibleNoteDiscount
43000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
750000 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-72000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-119000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-241000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-36000 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
140000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
105000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-172000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
188000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-23000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1813000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1037000 USD
mgt Release Of Restricted Cash And Cash Equivalents
ReleaseOfRestrictedCashAndCashEquivalents
2000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1671000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-212000 USD
mgt Payments For Reverse Or Forward Stock Split
PaymentsForReverseOrForwardStockSplit
0 USD
mgt Payments For Reverse Or Forward Stock Split
PaymentsForReverseOrForwardStockSplit
5000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3500000 USD
mgt Payments For Convertible Note Issuance Costs
PaymentsForConvertibleNoteIssuanceCosts
0 USD
mgt Payments For Convertible Note Issuance Costs
PaymentsForConvertibleNoteIssuanceCosts
-372000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3047000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3047000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3123000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
68000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2905000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1942000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3704000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5646000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
27000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 USD
mgt Noncash Or Part Noncash Acquisition Security Deposit
NoncashOrPartNoncashAcquisitionSecurityDeposit
2000 USD
mgt Noncash Or Part Noncash Acquisition Security Deposit
NoncashOrPartNoncashAcquisitionSecurityDeposit
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
32000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
440000 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4972000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
145000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
100000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
mgt Release Of Restricted Cash And Cash Equivalents
ReleaseOfRestrictedCashAndCashEquivalents
0 USD
CY2013Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.6312 pure
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
1500000 USD
CY2013Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
15512 shares
mgt Warrants Antidilutive
WarrantsAntidilutive
3015807 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
177336 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <em>Use of estimates</em></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 28.35pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 28.35pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div> </div>
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1400487 shares
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1680000 USD
CY2013Q2 mgt Warrants Exercised By Holders
WarrantsExercisedByHolders
715742 shares
CY2013Q2 mgt Warrants Antidilutive
WarrantsAntidilutive
3015807 shares
CY2013Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
700000 USD
CY2013Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
46000 USD
CY2013Q2 mgt Business Acquistion Purchase Price Allocation Assets Acquired
BusinessAcquistionPurchasePriceAllocationAssetsAcquired
339000 USD
CY2013Q2 mgt Fair Value Of Noncontrolling Interest
FairValueOfNoncontrollingInterest
1882000 USD
CY2013Q2 mgt Business Acquisition Total Fair Value Of Equity
BusinessAcquisitionTotalFairValueOfEquity
3018000 USD
CY2013Q2 mgt Business Acquisition Of Entity Cash Paid
BusinessAcquisitionOfEntityCashPaid
202000 USD
CY2013Q2 mgt Business Acquisition Aggregate Purchase Consideration
BusinessAcquisitionAggregatePurchaseConsideration
3220000 USD
CY2013Q2 mgt Business Acquisition Aggregate Fair Value Of Enterprise
BusinessAcquisitionAggregateFairValueOfEnterprise
5102000 USD
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
5102000 USD
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
-93000 USD
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
4000 USD
CY2013Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
-89000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
215000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
269000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-5871000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-2106000 USD
mgt Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-1.04
mgt Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-1.00
mgt Business Acquisition Pro Forma Shares Outstanding Basic And Diluted
BusinessAcquisitionProFormaSharesOutstandingBasicAndDiluted
5772423 shares
mgt Business Acquisition Pro Forma Shares Outstanding Basic And Diluted
BusinessAcquisitionProFormaSharesOutstandingBasicAndDiluted
2106763 shares
mgt Cash Received On Sale Of Patent
CashReceivedOnSaleOfPatent
651000 USD
CY2013Q2 us-gaap Escrow Deposit
EscrowDeposit
99000 USD
mgt Foreign Withholding Tax Amount
ForeignWithholdingTaxAmount
248000 USD
mgt Escrow Agent Fee
EscrowAgentFee
1000 USD
mgt Gross Proceeds From Sale Of Medical Patents
GrossProceedsFromSaleOfMedicalPatents
1500000 USD
mgt Net Proceeds From Sale Of Medical Patents
NetProceedsFromSaleOfMedicalPatents
750000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
1913000 USD
CY2012 mgt Finite Lived Intangible Asset Acquired Cash Paid
FiniteLivedIntangibleAssetAcquiredCashPaid
200000 USD
CY2012 mgt Warrant Term
WarrantTerm
P4Y
CY2012 mgt Stock Issued During Period Shares Purchase Of Warrants
StockIssuedDuringPeriodSharesPurchaseOfWarrants
350000 shares
CY2013Q2 mgt Intangible Assets Consideration Paid
IntangibleAssetsConsiderationPaid
25000 USD
CY2013Q2 mgt Adjustments To Additional Paid In Capital Reclassification Of Warrants Into Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIntoEquity
1164000 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
403029 shares
CY2013Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1164000 USD
CY2013Q2 mgt Cash And Cash Equivalents Including Restricted Cash
CashAndCashEquivalentsIncludingRestrictedCash
7137000 USD
us-gaap Restricted Cash And Cash Equivalent Item Description
RestrictedCashAndCashEquivalentItemDescription
Restricted cash includes $750 held in escrow relating to the sale of the Companys portfolio of medical imaging patents.
CY2012Q4 mgt Cash Maintenance Provision Limit On Shares
CashMaintenanceProvisionLimitOnShares
345012 shares
mgt Amount Released Out Of Restricted Cash
AmountReleasedOutOfRestrictedCash
2000000 USD
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
0 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
7166000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7166000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
0 USD
CY2013Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Instruments Classified In Shareholders Equity Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityTransfersNet
-9370000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
831000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1281000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8M12D
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.85
mgt Warrants Expiry Description
WarrantsExpiryDescription
all issued warrants are exercisable and expire through 2017
mgt Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercised
715742 shares
mgt Maximum Number Of Warrants Allowed
MaximumNumberOfWarrantsAllowed
1431486 shares
mgt Exchange Of Warrant Into Common Stock
ExchangeOfWarrantIntoCommonStock
894683 shares
mgt Common Stock Purchase Warrant Exercised
CommonStockPurchaseWarrantExercised
307204 shares
mgt Common Stock Purchase Warrant Exercise Price
CommonStockPurchaseWarrantExercisePrice
3.00
mgt Conversion Of Warrants To Cashless Shares
ConversionOfWarrantsToCashlessShares
210529 shares
mgt Conversion Of Warrants Exercised
ConversionOfWarrantsExercised
96675 shares
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
346000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
197000 USD
mgt Gain Loss On Mark To Market Of Intangible Assets
GainLossOnMarkToMarketOfIntangibleAssets
363000 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
4
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2303000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1795000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
249000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
118000 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1882000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-147000 USD
CY2013Q2 mgt Service Agreements Expenses Incurred During Period
ServiceAgreementsExpensesIncurredDuringPeriod
76000 USD
mgt Service Agreements Expenses Incurred During Period
ServiceAgreementsExpensesIncurredDuringPeriod
176000 USD
mgt Reduction In Cash Consideration
ReductionInCashConsideration
108000 USD
CY2013Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
100000 shares
CY2013Q2 mgt Reduction In Future Cash Consideration
ReductionInFutureCashConsideration
20000 USD
CY2013Q2 mgt Consideration Of Month To Month Service Agreement
ConsiderationOfMonthToMonthServiceAgreement
15000 USD
CY2013Q2 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y5M8D
CY2013Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2013Q2 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
3.85
CY2013Q2 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.00850 pure
CY2013Q2 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y5M8D
CY2013Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2013Q2 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
3.85
CY2013Q2 us-gaap Share Price
SharePrice
5.03
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1400487 shares
CY2013Q2 mgt Common Stock Purchase Warrant Exercised
CommonStockPurchaseWarrantExercised
307204 shares
CY2011Q3 mgt Refundable Rental Deposit
RefundableRentalDeposit
39000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
44000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
72000 USD
CY2012Q4 mgt Cash Consideration Payable Towards Consulting Agreement
CashConsiderationPayableTowardsConsultingAgreement
250000 USD
CY2012Q4 mgt Issuance Of Restricted Stock
IssuanceOfRestrictedStock
120000 shares
CY2013Q2 mgt Payment Towards Consultation Services
PaymentTowardsConsultationServices
62000 USD
mgt Payment Towards Consultation Services
PaymentTowardsConsultationServices
124000 USD
CY2011Q3 mgt Operating Leases Rental Payments Terms
OperatingLeasesRentalPaymentsTerms
P39M
CY2011Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-11-30
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
2000 USD
CY2011Q3 mgt Operating Leases Expenses For Rental Deposit Total
OperatingLeasesExpensesForRentalDepositTotal
240000 USD
CY2013Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
27000 USD
CY2012Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
36000 USD
CY2012Q4 mgt Operating Leases Expenses For Rental Deposit Total
OperatingLeasesExpensesForRentalDepositTotal
2000 USD
CY2012Q4 mgt Operating Leases Rental Payments Terms
OperatingLeasesRentalPaymentsTerms
P24M
CY2012Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-10-31
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
40000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
76000 USD
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
116000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
100000 USD
CY2013Q2 mgt Revenue
Revenue
67000 USD
CY2012Q2 mgt Revenue
Revenue
56000 USD
mgt Revenue
Revenue
153000 USD
mgt Revenue
Revenue
269000 USD

Files In Submission

Name View Source Status
0001144204-13-045995-index-headers.html Edgar Link pending
0001144204-13-045995-index.html Edgar Link pending
0001144204-13-045995.txt Edgar Link pending
0001144204-13-045995-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mgt-20130630.xml Edgar Link completed
mgt-20130630.xsd Edgar Link pending
mgt-20130630_cal.xml Edgar Link unprocessable
mgt-20130630_def.xml Edgar Link unprocessable
mgt-20130630_lab.xml Edgar Link unprocessable
mgt-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v351874_10q.htm Edgar Link pending
v351874_ex31-1.htm Edgar Link pending
v351874_ex31-2.htm Edgar Link pending
v351874_ex32-1.htm Edgar Link pending
v351874_ex32-2.htm Edgar Link pending